The NFATc2 Gene is involved in a novel cloned translocation in a ewing sarcoma variant that couples its function in immunology to oncology

Clinical Cancer Research

Volumn 15, Issue 7, 2009, Pages 2259-2268

  Szuhai, Károly ^a   Ijszenga, Marije ^a   De Jong, Danielle ^a   Karseladze, Apollon ^b   Tanke, Hans J ^a   Hogendoorn, Pancras C W ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR ERG; TRANSCRIPTION FACTOR ETS; TRANSCRIPTION FACTOR FLI 1;

ADOLESCENT; ADULT; ARTICLE; CARCINOGENESIS; CASE REPORT; CHROMOSOME 20; CHROMOSOME 22; COMPARATIVE GENOMIC HYBRIDIZATION; ESWR1 GENE; EWING SARCOMA; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE FUSION; GENE TRANSLOCATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; KARYOTYPING; MALE; MOLECULAR GENETICS; NFATC2 GENE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RING CHROMOSOME;

ADOLESCENT; ADULT; BONE NEOPLASMS; CALMODULIN-BINDING PROTEINS; CLONING, MOLECULAR; COMPARATIVE GENOMIC HYBRIDIZATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERPHASE; MALE; NFATC TRANSCRIPTION FACTORS; ONCOGENE PROTEINS, FUSION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA-BINDING PROTEINS; SARCOMA, EWING'S; SEQUENCE ANALYSIS, DNA; SEQUENCE ANALYSIS, PROTEIN; TRANSLOCATION, GENETIC; YOUNG ADULT;

EID: 65249099562     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-08-2184     Document Type: Article

References (36)

1. Fletcher CDM, Unni KK, Mertens F. World Health Organization classification of tumours. Pathology and genetics of tumours of soft tissue and bone. Lyon: IARC Press; 2002.
2. Sandberg AA, Bridge JA. Updates on cytogenetics and molecular genetics of bone and soft tissue tumors: Ewing sarcoma and peripheral primitive neuroectodermal tumors. Cancer Genet Cytogenet 2000; 123:1 -26.
3. Rossi S, Szuhai K, Ijszenga M, et al. EWSR1-1 and EWSR1-1 fusion genes in angiomatoid fibrous histiocytoma. Clin Cancer Res 2007;13:7322-8.
4. Mitelman F, Johansson B, Mertens F. Mitelman data-base of chromosome aberrations in cancer; 2008. Available from: http://cgap.nci.nih.gov/ Chromosomes/Mitelman.
5. Moller E, Stenman G, Mandahl N, et al. POU5F1, encoding a key regulator of stem cell pluripotency, is fused to EWSR1 in hidradenoma of the skin and mucoepidermoid carcinoma of the salivary glands. J Pathol 2008;215:78-86.
6. Janknecht R. EWS-ETS oncoproteins: the linchpins of Ewing tumors. Gene 2005;363:1 -14.
7. Bovee JVMG, Devilee P, Cornelisse CJ, Schuuring E, Hogendoorn PCW. Identification of an EWS-pseudogene using translocation detection by RT-PCR in Ewing's sarcoma. Biochem Biophys Res Commun 1995;213:1051 -60.
8. Verger A, Duterque-Coquillaud M. When Ets transcription factors meet their partners. Bioessays 2002;24:362-70.
9. Verger A, Buisine E, Carrere S, et al. Identification of amino acid residues in the ETS transcription factor Erg that mediate Erg-Jun/Fos-DNA ternary complex formation. J Biol Chem 2001;276:17181 -9.
10. Kim S, Denny CT, Wisdom R. Cooperative DNA binding with AP-1 proteins is required for transformation by EWS-Ets fusion proteins. Mol Cell Biol 2006; 26:2467-78.
11. Braunreiter CL, Hancock JD, Coffin CM, Boucher KM, Lessnick SL. Expression of EWS-ETS fusions in NIH3T3 cells reveals significant differences to Ewing's sarcoma. Cell Cycle 2006;5:2753-9.
12. Hancock JD, Lessnick SL. A transcriptional profiling meta-analysis reveals a core EWS-FLI gene expression signature. Cell Cycle 2008;7:250-6.
13. Macian F, Lopez-Rodriguez C, Rao A. Partners in transcription: NFAT and AP-1. Oncogene 2001;20: 2476-89.
14. Macian F. NFAT proteins: key regulators of T-cell development and function. Nat Rev Immunol 2005;5: 472-84.
15. Szuhai K, Ijszenga M, Tanke HJ, et al. Detection and molecular cytogenetic characterization of a novel ring chromosome in a histological variant of Ewing sarcoma. Cancer Genet Cytogenet 2007;172:12-22.
16. Knijnenburg J, van der BM, Tanke HJ, Szuhai K. Optimized amplification and fluorescent labeling of small cell samples for genomic array-CGH. Cytometry A 2007;71:585-91.
17. Szuhai K, Bezrookove V, Wiegant J, et al. Simultaneous molecular karyotyping and mapping of viral DNA integration sites by 25-color COBRA-FISH. Genes Chromosomes Cancer 2000;28:92-7.
18. Wiegant J, Kalle W, Mullenders L, et al. High- resolution in situ hybridization using DNA halo preparations. Hum Mol Genet 1992;1:587-91.
19. Szuhai K, Ijszenga M, Tanke HJ, Rosenberg C, Hogendoorn PCW. Molecular cytogenetic characterization of four previously established and two newly established Ewing sarcoma cell lines. Cancer Genet Cytogenet 2006;166:173-9.
20. Hogan PG, Chen L, Nardone J, Rao A. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev 2003;17:2205-32.
21. Rao A, Luo C, Hogan PG. Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol 1997;15:707-47.
22. Jin L, Sliz P, Chen L, et al. An asymmetric NFAT1 dimer on a pseudo-palindromic κB-like DNA site. Nat Struct Biol 2003;10:807-11.
23. Verhoeven DH, de Hooge AS, Mooiman EC, et al. NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways. Mol Immunol 2008;45:3917-25.
24. de Hooge AS, Berghuis D, Santos SJ, et al. Expression of cellular FLICE inhibitory protein, caspase-8, and protease inhibitor-9 in Ewing sarcoma and implications for susceptibility to cytotoxic pathways. Clin Cancer Res 2007;13:206-14.
25. Chen L, Glover JN, Hogan PG, Rao A, Harrison SC. Structure of the DNA-binding domains from NFAT, Fos and Jun bound specifically to DNA. Nature 1998; 392:42-8.
26. Ramirez-Carrozzi VR, Kerppola TK. Dynamics of Fos-Jun-NFAT1 complexes. Proc Natl Acad Sci U S A 2001;98:4893-8.
27. Marinescu VD, Kohane IS, Riva A. MAPPER: a search engine for the computational identification of putative transcription factor binding sites in multiple genomes. BMC Bioinformatics 2005;6:79.
28. Hollenhorst PC, Jones DA, Graves BJ. Expression profiles frame the promoter specificity dilemma of the ETS family of transcription factors. Nucleic Acids Res 2004;32:5693-702.
29. Aman P, Panagopoulos I, Lassen C, et al. Expression patterns of thehuman sarcoma-associated genes FUS and EWS and the genomic structure of FUS. Genomics 1996;37:1-8.
30. NgTL, O'Sullivan MJ, Pallen CJ, et al. Ewing sarcoma with novel translocation t(2;16) producing an in- frame fusion of FUS and FEV. J Mol Diagn 2007;9: 459-63.
31. Shing DC, McMullan DJ, Roberts P, et al. FUS/ERG gene fusions in Ewing's tumors. Cancer Res 2003;63: 4568-76.
32. Wang L, Bhargava R, Zheng T, et al. Undifferentiated small round cell sarcomas with rare EWS gene fusions: identification of a novel EWS-SP3 fusion and of additional cases with the EWS-ETV1 and EWS-FEV fusions. J Mol Diagn 2007;9:498-509.
33. Davis RJ, Barr FG. Fusion genes resulting from alternative chromosomal translocations are overexpressed by gene-specific mechanisms in alveolar rhabdomyosarcoma. Proc Natl Acad Sci U S A 1997; 94:8047-51.
34. Sandberg AA, Bridge JA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Dermatofibrosarcoma protuberans and giant cell fibroblastoma. Cancer Genet Cytogenet 2003; 140:1 -12.
35. Tomlins SA, Rhodes DR, Perner S, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 2005;310:644-8.
36. Tomlins SA, Laxman B, Dhanasekaran SM, et al. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature 2007;448:595-9.